Study on the Long-Term Safety of GTX-102 for Patients with Angelman Syndrome
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effectiveness of Ivosidenib or Enasidenib with Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia with IDH1 or IDH2 Mutations
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Guselkumab for Patients with Moderate to Severe Crohn’s Disease
Not recruiting
Investigated Drugs:
+4
powered by
